APcK 110
CAS: 1001083-74-4
Ref. 3D-BQB08374
| 1mg | A consultar | |
| 5mg | A consultar | |
| 10mg | A consultar | |
| 25mg | A consultar | |
| 50mg | A consultar |
Informação sobre produto
APCK-110 is a tyrosine kinase inhibitor that has been shown to inhibit the constitutive activation of the mastocytosis receptor tyrosine kinase, KIT. APCK-110 has also demonstrated efficacy in clinical studies involving patients with leukemia who were resistant to imatinib and dasatinib. The drug inhibits proliferation of cancer cells, and may also be able to differentiate between leukemias and stem cells. The drug has been shown to have toxicities, such as anemia, neutropenia, thrombocytopenia, and hepatotoxicity. These toxicities are dose-dependent, with the most severe side effects seen at high doses.
Propriedades químicas
Consulta técnica sobre: 3D-BQB08374 APcK 110
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
